Vaxart was classified in the Zacks Medical - Drugs industry as of August 14, 2025.
1 report, 1 independent
Updated Aug 14
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Vaxart was classified in the Zacks Medical - Drugs industry as of August 14, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Vaxart
American biotechnology company based in San Francisco
Nothing else this week.
Coverage
Newest first; wire copies grouped- ZacksVAXART, INC. (VXRT) Reports Q2 Loss, Beats Revenue Estimates VAXART, INC. (VXRT) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compare